GLP-1 receptors are found in several brain regions, including: The ventral tegmental area (VTA) The nucleus accumbens The prefrontal cortex When activated by GLP-1, these receptors appear to reduce the release of dopamine in response to addictive substances
Vigorous shaking can damage the delicate peptide chains through mechanical stress, a process called shearing
Understanding your genetic predispositions in GLP-1 and glucose-sensing pathways can help you and your provider make data-informed decisions about compounded GLP-1 therapies (semaglutide, tirzepatide) versus lifestyle interventions, or whether a combination approach is most suitable for your metabolic health goals
A couple of years ago, 22 states exceeded that rate
Arora, G., Arora, S., Sadoughifar, R., & Batra, N